Wednesday, March 31, 2004
G-Oh Canada
According to the Mass Biotech Council, the biotech industry is concerned about legislation that would allow the importation of cheaper drugs from Canada (source: Boston Globe, 3/20/2004) imports that would undercut drugs made in Massachusetts, and possible cost the industry jobs.
So what is Willard Mitt doing to strengthen the biotech industry and save jobs?
Well, last October, after AG Tom Reilly called on the US Food and Drug Administration to set up secure channels for Americans to get discount medicine from Canada an aide to Romney?s $150,000-a-year loathsome spokesman said the administration was studying the prescription drug issue but had taken no position. (source: Boston Globe, 10/14/2003)
And recently, when a legislative panel gave preliminary approval to a bill allowing Canadian drugs to be imported to Massachusetts, the self-same aide said Willard Mitt had not seen the latest bill and had no comment. (source: Boston Globe, 3/18/2004)
Meanwhile, Scott Sarazen, who is Romney's 'life-science development official' (is that a civil service designation?) admits that Massachusetts has "historically been complacent" about the biotech industry, but claims the state is trying to do better. (source: Christian Science Monitor, 12/26/2003)
Yet when it comes to one of the most important bills to ever face the biotech industry, Willard Mitt has not taken a position, and has no comment.
Who knew the Fraud Governor was such a stickler for historical precedent.
According to the Mass Biotech Council, the biotech industry is concerned about legislation that would allow the importation of cheaper drugs from Canada (source: Boston Globe, 3/20/2004) imports that would undercut drugs made in Massachusetts, and possible cost the industry jobs.
So what is Willard Mitt doing to strengthen the biotech industry and save jobs?
Well, last October, after AG Tom Reilly called on the US Food and Drug Administration to set up secure channels for Americans to get discount medicine from Canada an aide to Romney?s $150,000-a-year loathsome spokesman said the administration was studying the prescription drug issue but had taken no position. (source: Boston Globe, 10/14/2003)
And recently, when a legislative panel gave preliminary approval to a bill allowing Canadian drugs to be imported to Massachusetts, the self-same aide said Willard Mitt had not seen the latest bill and had no comment. (source: Boston Globe, 3/18/2004)
Meanwhile, Scott Sarazen, who is Romney's 'life-science development official' (is that a civil service designation?) admits that Massachusetts has "historically been complacent" about the biotech industry, but claims the state is trying to do better. (source: Christian Science Monitor, 12/26/2003)
Yet when it comes to one of the most important bills to ever face the biotech industry, Willard Mitt has not taken a position, and has no comment.
Who knew the Fraud Governor was such a stickler for historical precedent.
